In 2019, a chance meeting in a shared office space in central London sparked a collaboration that has since bridged cosmology and cancer research. James Nightingale, a young cosmologist from Durham University studying dark matter, was discussing data challenges posed by the Euclid space telescope with a friend skilled in computer coding. Their conversation turned to nested sampling, a statistical technique aimed at protecting Euclid’s instruments from stellar radiation. At that moment, Matthew Griffiths, who had recently left Cambridge to found a cancer research startup called Concr, overheard the term and joined the discussion.

Griffiths had applied nested sampling in his atomic chemistry research and saw potential for its use in modeling radiation-induced cell damage in humans. This interdisciplinary exchange led to the development of a tool that Concr now uses to personalize chemotherapy treatments. By analyzing large datasets from patients’ medical histories and clinical trials, the company can identify with approximately 85% to 90% confidence which chemotherapy drugs are unlikely to benefit individual patients, potentially reducing the toxicity associated with indiscriminate drug cocktails.

The collaboration also benefited the original cosmology team; using the same analytical methods, they advanced efforts to understand dark matter, an elusive substance that constitutes about 85% of the universe’s mass. The Euclid telescope, currently scanning the cosmos, provides data that can be processed using these statistical tools, demonstrating how methods from one field can be adapted to another.

This intersection of disciplines exemplifies a broader trend in science that embraces what is often termed “serendipity”: unexpected interactions between researchers from different fields leading to innovation. Paul Nurse, president of the Royal Society and Nobel laureate, emphasizes that high-quality scientific inquiry often thrives on exploring unexpected connections. He points out that interdisciplinary collaboration facilitates these moments by breaking down traditional academic silos.

Institutions like the Francis Crick Institute in London have deliberately designed their research environments to encourage such interactions. Rejecting departmental divisions, the Crick employs shared labs and communal spaces to foster informal discussions. Architecturally, a prominent spiral staircase was maintained specifically to promote encounters, as Nurse observed that people are more likely to converse on stairs than in elevators.

This approach is not unique to the Crick. Historical precedents include the Manhattan Project and MIT’s Building 20, where flexible, open spaces encouraged collaboration during World War II. More recently, research hubs and startup incubators in global cities—such as Station F in Paris, Brooklyn Navy Yard in New York, and the White City campuses at Imperial College London—have embraced design features aimed at enhancing scientific cross-pollination.

Imperial College itself has benefited from such serendipitous interactions. Ecologist Sarab Sethi, for example, connected with electronics engineer Clementine Boutry to develop biodegradable microphones for monitoring biodiversity in remote forests. Meanwhile, James MacDonald, a materials scientist, collaborated with chemists to create a new biodegradable material inspired by artificial protein design, now being commercialized in the sportswear industry.

While the benefits of interdisciplinary encounters are widely recognized, questions remain about the extent to which serendipitous breakthroughs can be systematically engineered. Alexander Krauss, a researcher at the London School of Economics, studied over 750 Nobel-worthy discoveries and found that factors such as researcher age and institutional prestige did not necessarily predict success, nor did funding trends correlate strongly with scientific breakthroughs.

The challenge today lies in managing the vast volume of scientific literature—over three million papers were published in the prior year alone—that can overwhelm researchers seeking relevant insights outside their immediate fields. Paul Nurse advocates for a wide-ranging curiosity and open dialogue within laboratories to identify unexpected links that may prompt new discoveries.

From the discovery of penicillin by Alexander Fleming to modern advances at the intersection of physics, biology, and computer science, the history of science underscores that chance encounters and interdisciplinary exchange often fuel progress. As institutions continue to foster environments that encourage such interactions, the hope is to harness serendipity not just as luck but as a deliberate driver of innovation.